#41: The ISCHEMIA trial on optimal care for patients with stable coronary disease with Dr Judith Hochman

Dr Robert Harrington

Disclosures

October 06, 2011

This feature requires the newest version of Flash. You can download it here.

Both cardiologists and patients grapple with the concept that fixing a blockage may not prolong life, as indicated by the results of the landmark COURAGE and BARI 2D trials and reflected by the limited effect these trials seem to have had on clinical practice.

The large ISCHEMIA trial, led by Dr Judith Hochman, seeks to build on the results of COURAGE and BARI 2D to answer the important question: what is the best treatment for patients with stable coronary disease?

Dr Hochman joins the show to discuss rationale and trial design and give information on how to become involved in the study.

For more information on ISCHEMIA, click here.

To contact the study organizers, click here.

Dr Hochman has no relevant financial disclosures.

For Dr Harrington's disclosures, click here.

See also:

 

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....